Literature DB >> 25616697

Role of vitamin D receptor gene polymorphisms in pancreatic cancer: a case-control study in China.

Lei Li1, Feifei Shang, Weihui Zhang, Canhong Zhang, Junshan Li, Changhui Wang, Lin Wei.   

Abstract

The study was conducted to investigate the relationship between vitamin D receptor (VDR) gene rs2228570 and rs1544410 polymorphisms and pancreatic cancer (PC). Two hundred fifty-eight PC patients and 385 healthy controls were enrolled in this study. The genotypes of rs2228570 and rs1544410 were assayed using the polymerase chain reaction/restriction fragment length polymorphism (PCR-RFLP) method. Univariate and multivariate logistic regression analyses were applied to determine the association between PC-onset risk and VDR gene polymorphisms. Contingency table analysis was performed to evaluate the relationship between the gene polymorphisms and clinicopathological tumor features such as location, pathological differentiation, and the TNM classification of PC. In rs2228570, the T loci and genotypes with T allele could increase the risk of PC; in rs1544410, the G loci and genotypes AG + GG could decrease the onset risk of PC significantly. The contingency table analysis indicated that the rs2228570 polymorphisms were correlated with the pathological differentiation of PC significantly, and the rs1544410 polymorphisms were correlated with the TNM classification of PC significantly. In conclusion, the VDR gene polymorphisms were correlated with incidence, pathological differentiation, and the TNM classification of PC significantly in our study population. So, the VDR polymorphisms have important implications in the incident rate and survival rate of PC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25616697     DOI: 10.1007/s13277-015-3119-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  48 in total

Review 1.  Molecular nature of the vitamin D receptor and its role in regulation of gene expression.

Authors:  P W Jurutka; G K Whitfield; J C Hsieh; P D Thompson; C A Haussler; M R Haussler
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

2.  Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin.

Authors:  M J Campbell; E Elstner; S Holden; M Uskokovic; H P Koeffler
Journal:  J Mol Endocrinol       Date:  1997-08       Impact factor: 5.098

3.  Diet and pancreatic cancer: a case-control study.

Authors:  S E Norell; A Ahlbom; R Erwald; G Jacobson; I Lindberg-Navier; R Olin; B Törnberg; K L Wiechel
Journal:  Am J Epidemiol       Date:  1986-12       Impact factor: 4.897

Review 4.  1α,25(OH)2-dihydroxyvitamin D3/VDR protects the skin from UVB-induced tumor formation by interacting with the β-catenin pathway.

Authors:  Yan J Jiang; Arnaud E Teichert; Frankie Fong; Yuko Oda; Daniel D Bikle
Journal:  J Steroid Biochem Mol Biol       Date:  2012-09-28       Impact factor: 4.292

Review 5.  The epidemiology of pancreatitis and pancreatic cancer.

Authors:  Dhiraj Yadav; Albert B Lowenfels
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

Review 6.  [The role of vitamin D in the prevention and the additional therapy of cancers].

Authors:  Gábor Speer
Journal:  Magy Onkol       Date:  2010-12

7.  MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase.

Authors:  Kun-Chun Chiang; Chun-Nan Yeh; Jun-Te Hsu; Li-Wei Chen; Sheng-Fong Kuo; Chi-Chin Sun; Cheng-Cheng Huang; Jong-Hwei S Pang; John N Flanagan; Masashi Takano; Atsushi Kittaka; Horng-Heng Juang; Shih-Wei Yang; Tai C Chen
Journal:  J Steroid Biochem Mol Biol       Date:  2013-09-14       Impact factor: 4.292

8.  Vitamin D receptor (VDR) gene polymorphisms and Graves' disease: a meta-analysis.

Authors:  Haiyang Zhou; Chenggang Xu; Mingjun Gu
Journal:  Clin Endocrinol (Oxf)       Date:  2008-09-08       Impact factor: 3.478

9.  Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine.

Authors:  Dan Laheru; Barbara Biedrzycki; Elizabeth M Jaffee
Journal:  Methods Mol Biol       Date:  2013

10.  Plasma Vitamin D Levels And Vitamin D Receptor Polymorphisms Are Associated with Survival of Non-small Cell Lung Cancer.

Authors:  Yao Liu; Wei Chen; Zhi-Bin Hu; Lin Xu; Yong-Qian Shu; Shi-Yang Pan; Jun-Cheng Dai; Guang-Fu Jin; Hong-Xia Ma; Hong-Bing Shen
Journal:  Chin J Cancer Res       Date:  2011-03       Impact factor: 5.087

View more
  5 in total

1.  Pre-treatment VD levels and VDR receptors as potential predictors of occurrence and overall survival in paediatric patients with solid tumours-a single institution pilot study.

Authors:  Julie Bienertová-Vašků; Klára Drábová; Filip Zlámal; Josef Tomandl; Michal Kýr; Zbyněk Šplíchal; Jaroslav Štěrba
Journal:  Tumour Biol       Date:  2016-01-14

2.  Vitamin D receptor rs2228570 polymorphism is associated with LH levels in men exposed to anabolic androgenic steroids.

Authors:  Linda Björkhem-Bergman; Mikael Lehtihet; Anders Rane; Lena Ekström
Journal:  BMC Res Notes       Date:  2018-01-19

3.  A systematic review and network meta-analysis of single nucleotide polymorphisms associated with pancreatic cancer risk.

Authors:  Zhuo-Miao Ye; Li-Juan Li; Ming-Bo Luo; Hong-Yuan Qing; Jing-Hui Zheng; Chi Zhang; Yun-Xin Lu; You-Ming Tang
Journal:  Aging (Albany NY)       Date:  2020-11-20       Impact factor: 5.682

4.  Association Between Vitamin D Binding Protein Gene Polymorphism (rs7041), Vitamin D Receptor, and 25-Hydroxyvitamin D Serum Levels With Prostate Cancer in Kurdish Population in West of Iran.

Authors:  Mohammad Amiri; Daniel Elieh Ali Komi; Asad Vaisi-Raygani; Amir Kiani; Mahmoudreza Moradi; Mahdieh Aliyari; Zohreh Rahimi; Ehsan Mohammadi-Noori; Homayoon Bashiri
Journal:  Pathol Oncol Res       Date:  2022-08-09       Impact factor: 2.874

5.  Association of vitamin D receptor variants with clinical parameters in prostate cancer.

Authors:  Sarah Braga Rodrigues Nunes; Fabrícia de Matos Oliveira; Adriana Freitas Neves; Galber Rodrigues Araujo; Karina Marangoni; Luiz Ricardo Goulart; Thaise Gonçalves Araújo
Journal:  Springerplus       Date:  2016-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.